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Radiation injury to the skin is one of the major limiting factors in radiotherapy. This study investigated whether 
extracts of soybean seeds (EOS), [Glycine max (L.) Merr.], reduced radiation dermatitis induced by radiation. We 
studied 27 Sprague-Dawley rats, which were divided into three groups, to evaluate the reduction in skin injury using 
natural products from soybean seeds as protection against radiation. Radiation dermatitis in EOS-treated animals 
(0.25 g/cm2 skin once daily) was less severe than that in the control group after 50 Gy of radiation. Within 29 days 
after radiation, the skin scores in the control group were higher than those in the EOS group (0.5 in the EOS group vs. 
1 in the control group; p < 0.05). The histologic findings indicated that skin reactions after 50 Gy of radiation were 
mild in both groups. However, the skin reactions in the EOS group were less prominent than those in the control 
group. The EOS-treated rats had normal hair growth, but hair growth was suppressed in control rats. We conclude 
that EOS are able to reduce reactions to radiation and can achieve a better recovery in the skin.
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Introduction
Radiation injury to the skin is one of the most com-
mon adverse effects of radiation therapy. The acute 
skin reaction to radiation involving swelling, des-
quamation and ulceration usually causes significant 
pain, thereby becoming a limiting factor for radia-
tion therapy. Topical application of steroidal or non-
steroidal anti-inflammatories is the most common 
treatment for radiation injury of the skin; yet, the 
results are unsatisfactory and local toxicity has been 
noted.1 Several experimental and clinical studies 
have suggested that extracts from plants can reduce 
radiation injury of the skin.2,3
Soybean and its related derivatives are health 
foods with high levels of protein and essential amino 
acids, omega-3 fatty acids, fat-soluble vitamins, 
polysaccharides, and insoluble fibers.4 In particular, 
soybeans are a rich and relatively unique source of 
isoflavones. Soybeans are known to contain the five 
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isoflavone glycosides, i.e. genistin, daidzin, glycitin, 
6″-O-acetylgenistin, and 6″-O-acetyldaidzin, and 
their corresponding aglycons, i.e. daidzein, glycitein, 
and genistein.5 It has been reported that isoflavone 
compounds possess antihemolytic, antioxidative, 
antifungal, estrogenic and antitumoral activities.6−9 
Soybean extracts have been marketed, and the 
patent number is US007112344B2.
In a pilot study, we found that extracts of soybean 
seeds (EOS) reduce the healing time after radiation-
induced skin injury. Because EOS exhibit a protec-
tive effect against radiation injury, they may be an 
effective agent for use with radiation therapy. There-
fore, we designed this study to assess whether EOS 
can reduce acute radiation reactions in rat skin. 
The anti-radiation dermatitis activity was deter-
mined to explore potential therapeutic uses.
Materials and Methods
Adult female Sprague-Dawley rats purchased from 
the Laboratory Animal Center of the National Cheng 
Kung University of Taiwan, weighing 250−300 g at 
the time for irradiation, were used in these exper-
iments. Each rat was caged alone and allowed free 
access to chow and water. After a week of acclima-
tion, rats were anesthetized with pentobarbital so-
dium salt (C11H17N2NaO3; TCI, Tokyo, Japan) 50 mg/kg 
intraperitoneally before irradiation. The skin over 
the gluteal area was completely shaved, and radi-
ation fields were outlined with a marking pen on 
the right gluteus just prior to irradiation. Twenty-
seven rats were equally divided into three groups: 
the first group (EOS group) was shaved and had radi-
ation with EOS treatment; the second group operated 
as the control group (shaved and given radiation 
without drug treatment); and a third group was a 
sham group (shaved but did not receive radiation 
or drugs). The gross skin reactions were evaluated 
in all of the groups.
EOS were purchased from the manufacturer 
(Charsire Biotechnology Corp., Kaohsiung, Taiwan). 
EOS were applied topically to the irradiated area 
every day until 30 days after radiation. The mean 
dosage in the respective groups was 0.25 g/cm2 
skin once daily.
The gluteal area prepared for radiation received 
50 Gy of radiation in 10 fractions over 5 weeks. An 
electron beam with 6 MeV energy produced by a lin-
ear accelerator (Clinac 2100; Varian, Inc., CA, USA) 
was used at a dose rate of 2.4 Gy/min. The dose was 
delivered to the prepared area after the rats were 
anesthetized using a fixed target-to-source distance 
of 100 cm, and a radiation field size of 2 × 2 cm. Rats 
were constantly monitored during irradiation.
Acute skin reactions were evaluated and scored 
every other day until the 30th day after 50-Gy irradia-
tion using the modified skin score system proposed 
by Abe and Urano10 as follows: 0 = normal; 0.5 = slight 
epilation in < 50% of the radiation area; 1.0 = epila-
tion in 50% of the area; 1.5 = epilation in > 50% of the 
area; 2.0 = complete epilation; 2.5 = complete epi-
lation with definite edema or dry desquamation 
in > 50% of the area; 3.0 = moist desquamation in a 
small area; and 3.5 = moist desquamation in most of 
the area. The skin reaction was scored three times 
per week by a radiation oncologist and a pathologist.
Skin samples were taken after sacrificing the 
rats on day 30. Each specimen was embedded in a 
paraffin block, and thin sections were prepared, 
stained by the hematoxylin-eosin method and ex-
amined by a pathologist under a light microscope.
The microscopic findings involving the skin re-
actions were categorized into swelling of the en-
dothelium, mild atrophy of the epidermis, moderate 
dermal fibrosis with radiation atypia, and advanced 
atrophy of skin appendages.
A two-way analysis of variance test and repeated 
measures analysis of variance test were used to 
analyze variances and determine p values for multi-
ple test groups.11,12 We performed statistical anal-
ysis using a SAS program (SAS Institute, Cary, NC, 
USA). All p values were two-tailed and considered 
statistically significant if less than 0.05.
Results
The EOS treatment was well tolerated without any 
toxic effects. All the rats gained weight during the 
experimental period, and the mean body weights in 
the sham, control and EOS groups did not differ sig-
nificantly at the end of the study (Table 1). The mean 
Table 1 Mean body weight of Sprague-Dawley rats at day 0 and day 29 after irradiation*
 Treatment group
 Sham group Control group EOS group 
p
Weight at day 0 (g) 265.0 ± 9.8 287.3 ± 21.2 279.8 ± 6.4 0.58
Weight at day 29 (g) 295.0 ± 2.6 318.3 ± 26.7 312.7 ± 8.1 0.66
*Data are presented as mean ± standard deviation. EOS: extracts of soybean seeds.
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body weights of these three groups were not statis-
tically significant on either day 0 (p = 0.58) or day 
29 (p = 0.66).
The average skin reaction scores in each group 
are shown in Figure 1. The skin reactions in the EOS-
treated rats tended to be less marked than those 
in the control group at the same irradiation dosage. 
Figure 1 Time course of the average skin score after 
50-Gy irradiation. Error bars indicate ± standard error. 
†p ≤ 0.001; ‡p < 0.05, for the group treated with extracts 
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The control group showed a greater skin reaction 
than the EOS group on day 3 after irradiation (mean 
skin score, 0.5 in the control group and 0.125 in the 
EOS-treated group). By day 21, the dermatitis in the 
control group treated with 50 Gy had progressed to 
50% epilation, whereas in the EOS group, healing 
had begun and it continued to improve (p = 0.001). 
EOS appeared to reduce early skin reactions (days 
9−15) after 50 Gy of radiation (p = 0.004). The mean 
skin score of rats treated with EOS was significantly 
lower than that in the control group at the same 
radiation dose (0.5 vs. 1; p < 0.05; Figure 1).
There were no apparent changes in the histo-
logic findings between the control and EOS groups 
(Figure 2). Skin reactions after 50 Gy of radiation 
were mainly mild in both groups. However, the skin 
reactions in the EOS group were less prominent 
than those in the control group receiving the same 
dose of radiation (Table 2). The EOS-treated rats 
had normal hair growth (Figure 3A). Hair growth was 
suppressed in the control group compared with the 
EOS group (Figure 3B).
Discussion
Radiation injury to the skin is mainly caused by cell 
damage secondary to the production of free radicals, 
A B
C
Figure 2 Histologic findings in the skin at day 30 after 
50-Gy irradiation. (hematoxylin and eosin, 100 ×). The 
irradiated skin of rats treated with extracts of soybean 
seeds (EOS) was covered by multiple layers of epithelial 
cells on the epidermis and had more follicles than in the 
control group. (A) Sham group, (B) control group, and (C) 
EOS group.
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release of inflammatory mediators/cytokines, and 
the subsequent inflammatory reaction. The mech-
anism of radiation dermatitis is likely to be a multi-
step process involving unspecified cellular and 
humoral events.13,14
The practical significance of radioprotective com-
pounds is undisputed. Glucocorticoids can interfere 
with the inflammatory process by inhibiting phos-
pholipase A2.15,16 The effect of steroids on radiation 
dermatitis remains controversial as shown by previ-
ous clinical trials. Glees et al17 suggested that nei-
ther hydrocortisone nor clobetasone creams should 
be used as a treatment of choice to control radiation 
Table 3 Effects of extracts of soybean seeds (EOS), corticosteroids, non-steroids and vitamins on radiation dermatitis
   
Non-steroid 
 EOS Corticosteroids anti-inflammatory Vitamin C
   drug
Advantage Reduces inflammation;  Reduces inflammation Reduces Most cost effective
  earlier repair than the   inflammation  compared with the
  other three drugs    other three drugs
Disadvantage More expensive than Local toxicity1 Local toxicity1 No significant effect on
  the other three drugs    radiation dermatitis19
Cost 15 mL/tube, NT$350 Fluocinonide (Topsym lotion) Etofenamate gel,  Ascormin, 50 mg/
   0.05%, 10 g/bottle, NT$90  40 g/tube, NT$91  tablet, NT$2
Figure 3 Photographic records of the skin reaction of rats at day 30 after 50-Gy irradiation. (A) Hair growth was sup-
pressed, and the hair was not completely grown in the control group. (B) In the rats treated with extracts of soybean 
seeds, the irradiated region had normal hair growth.
A B
Table 2 Histologic findings in irradiated rat skin
Skin Control EOS





EOS: extracts of soybean seeds; A: swelling of the endothelium; 
B: mild atrophy of the epidermis; C: dermal fibrosis with radia-
tion atypia, moderate; D: atrophy of skin appendages.
dermatitis, and Potera et al18 found that topical 
cortisone cream had no prophylactic effects on radi-
ation dermatitis. Vitamin C, which is an antioxidant, 
also has no significant ability to prevent radiation 
dermatitis.19 Rather than focusing on agents acting 
on only a few steps in the inflammatory reaction, 
attempts to find effective anti-inflammatory agents 
to treat radiation dermatitis should focus on drugs 
with a broad anti-inflammatory profile.
Soybeans possess a remarkable cardiovascular 
protective effect.20 In a well-established nonhu-
man primate model of atherosclerosis, soy isofla-
vones were found to provide an anti-inflammatory 
effect specific for serum soluble vascular cell adhe-
sion molecule 1.21 It has been shown that supple-
mental isoflavones appear to be protective against 
DNA damage in postmenopausal women.22 Anti-
inflammatory properties of a soybean-derived Kunitz 
trypsin inhibitor at the level of gingival fibroblasts 
have been identified.23 Genistin, the principal iso-
flavone present in soy, has been identified as a 
protein tyrosine kinase inhibitor that has in vitro 
and in vivo anti-inflammatory effects. It suppresses 
the production of lipopolysaccharide-induced tumor 
necrosis factor α, interleukin 1β, and interleukin 6 
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in the liver and in the sera.24 Experiments in vivo 
have shown that soybean germ oil possesses a re-
markable protective activity against UV-B-induced 
skin inflammation, exceeding that of tocopherol 
acetate by a factor of 2.25 To the best of our knowl-
edge, this is the first reported investigation to use 
soybean-derived extract for radiation dermatitis. 
In our study, the therapeutic effect of EOS on ra-
diation dermatitis may be mediated by gradually 
converting skin injury from the inflammatory phase 
to the recovery phase.
Our histologic findings demonstrated that EOS 
treatment can reduce inflammation in irradiated 
rat skin. In general, the skin reactions in the control 
group occurred earlier and were more prominent 
than those in the EOS group. For example, moder-
ate dermal fibrosis with radiation atypia and atro-
phy of skin appendages were observed in the control 
group, whereas these effects were not seen in the 
EOS group. The histologic findings in the EOS-treated 
rats indicated that EOS may reduce radiation derma-
titis via anti-inflammatory processes. We compared 
the different effects of radiation dermatitis between 
EOS and other previously mentioned drugs in the 
literature1,19 (such as corticosteroids, non-steroids, 
and vitamin C) in Table 3.
Effective drugs for radiation dermatitis have not 
previously been reported to have antitumor activity. 
EOS can induce apoptosis and inhibit clonogenicity 
in prostate and colon cancer.5,9 This agent could be 
beneficial for clinical oncology, and further inves-
tigation on soybeans is needed in the future.
In conclusion, to treat clinical radiation derma-
titis, topical drugs should be applied cautiously to 
avoid establishing a build-up region by scattering 
rays, which may increase the skin dose and exac-
erbate the degree of radiation dermatitis. In our 
study, EOS-treated rats with radiation dermatitis 
developed a less severe reaction and earlier repair 
in the skin than in the control group. The dose we 
used (0.25 g/cm2 skin per day) in our study was ef-
fective in treatment of radiation dermatitis, but 
the optimal dose remains to be determined in fur-
ther experiments.
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